Top Markets
Coin of the day
Meribank Biotech Co., Ltd Meribank Biotech Co., Ltd

Meribank Biotech Co., Ltd

4724
Rank in Stocks #28629
Meribank Biotech Co., Ltd, established in 2013 and headquartered in Taipei... Meribank Biotech Co., Ltd, established in 2013 and headquartered in Taipei City, Taiwan, is a company dedicated to the cultivation, advancement, and banking of mesenchymal stem cells. The firm specializes in the preservation of various cell types, including mesenchymal stem cells sourced from the placenta and umbilical cord, hematopoietic stem cells from cord blood, and diverse immune cells. Additionally, Meribank is involved in developing advanced cellular cryopreservation protocols and provides postpartum nursing services.
Share Price
$0.27633355
Market Cap
$26.52M
Change (1 day)
-0.57%
Change (1 year)
-50.61%
Country
TW
Trade Meribank Biotech Co., Ltd (4724)

Category

P/B ratio for Meribank Biotech Co., Ltd (4724)
P/B ratio as of 2026 TTM: 0
According to Meribank Biotech Co., Ltd latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Meribank Biotech Co., Ltd from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
6.3419 -
US
3.7087 -
US
6.2413 -
NL
2.5054 -
AU
- -
CH